These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31313688)

  • 1. Intestinal failure-associated liver disease in adult patients.
    Morgan J; Dibb M; Lal S
    Curr Opin Clin Nutr Metab Care; 2019 Sep; 22(5):383-388. PubMed ID: 31313688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN.
    Lal S; Pironi L; Wanten G; Arends J; Bozzetti F; Cuerda C; Joly F; Kelly D; Staun M; Szczepanek K; Van Gossum A; Schneider SM;
    Clin Nutr; 2018 Dec; 37(6 Pt A):1794-1797. PubMed ID: 30017241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the management of intestinal failure-associated liver disease.
    Wiles A; Woodward JM
    Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):265-72. PubMed ID: 19339882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: diagnosis and management of intestinal failure-associated liver disease in adults.
    Bond A; Huijbers A; Pironi L; Schneider SM; Wanten G; Lal S
    Aliment Pharmacol Ther; 2019 Sep; 50(6):640-653. PubMed ID: 31342540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal failure-associated liver disease in the neonatal ICU: what we know and where we're going.
    Khalaf RT; Ford SL
    Curr Opin Pediatr; 2022 Apr; 34(2):184-190. PubMed ID: 35051980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease.
    Diamond IR; Pencharz PB; Feldman BM; Ling SC; Moore AM; Wales PW
    Arch Pediatr Adolesc Med; 2012 May; 166(5):473-8. PubMed ID: 22566549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into intestinal failure-associated liver disease in adults: A comprehensive review of the literature.
    Fousekis FS; Mitselos IV; Christodoulou DK
    Saudi J Gastroenterol; 2021; 27(1):3-12. PubMed ID: 33642350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction, identification and progression of histopathological liver disease activity in children with intestinal failure.
    Mutanen A; Lohi J; Merras-Salmio L; Koivusalo A; Pakarinen MP
    J Hepatol; 2021 Mar; 74(3):593-602. PubMed ID: 33002568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal failure-associated liver disease: causes, manifestations and therapies.
    Rochling FA; Catron HA
    Curr Opin Gastroenterol; 2019 Mar; 35(2):126-133. PubMed ID: 30585838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current strategies for managing intestinal failure-associated liver disease.
    Secor JD; Yu L; Tsikis S; Fligor S; Puder M; Gura KM
    Expert Opin Drug Saf; 2021 Mar; 20(3):307-320. PubMed ID: 33356650
    [No Abstract]   [Full Text] [Related]  

  • 11. New Insights Into Intestinal Failure-Associated Liver Disease in Children.
    Khalaf RT; Sokol RJ
    Hepatology; 2020 Apr; 71(4):1486-1498. PubMed ID: 32003009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children.
    Norsa L; Nicastro E; Di Giorgio A; Lacaille F; D'Antiga L
    Nutrients; 2018 May; 10(6):. PubMed ID: 29882922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of lipid emulsions in the prevention of intestinal failure-associated liver disease.
    Lim J; Oschman A; Curiel K
    Curr Opin Organ Transplant; 2019 Apr; 24(2):188-192. PubMed ID: 30762667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric intestinal failure-associated liver disease.
    Courtney CM; Warner BW
    Curr Opin Pediatr; 2017 Jun; 29(3):363-370. PubMed ID: 28333693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
    J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Insights Regarding Intestinal Failure-Associated Liver Disease (IFALD): A Narrative Review.
    Zafirovska M; Zafirovski A; Rotovnik Kozjek N
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral nutrition-associated liver injury: clinical relevance and mechanistic insights.
    Mihajlovic M; Rosseel Z; De Waele E; Vinken M
    Toxicol Sci; 2024 Apr; 199(1):1-11. PubMed ID: 38383052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevention and treatment of intestinal failure-associated liver disease in neonates and children.
    Nehra D; Fallon EM; Puder M
    Surg Clin North Am; 2011 Jun; 91(3):543-63. PubMed ID: 21621695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future.
    Carter BA; Karpen SJ
    Semin Liver Dis; 2007 Aug; 27(3):251-8. PubMed ID: 17682972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Intestinal Failure Associated Liver Disease according to different diagnostic criteria.
    Sasdelli AS; Agostini F; Pazzeschi C; Guidetti M; Lal S; Pironi L
    Clin Nutr; 2019 Jun; 38(3):1198-1205. PubMed ID: 29778510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.